Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Tiziana Life Sciences Ltd

TLSA
Current price
0.92 USD +0.0073 USD (+0.80%)
Last closed 0.94 USD
ISIN BMG889121031
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 96 555 392 USD
Yield for 12 month +66.54 %
1Y
3Y
5Y
10Y
15Y
TLSA
21.11.2021 - 28.11.2021

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), an orally bioavailable small molecule broad spectrum inhibitor of various cyclin-dependent kinases and Src family; and TZLS-501, a fully human mAb targeting the IL-6 receptor for the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom. Address: 14/15 Conduit Street, London, United Kingdom, W1S 2XJ

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-51 000 USD

Current Quarter

Last Quarter

-46 000 USD

Key Figures TLSA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -15 788 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -69.58 %
PEG Ratio
Return On Equity TTM -181.23 %
Wall Street Target Price 3 USD
Revenue TTM -3 595 000 USD
Book Value 0.018 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.13 USD
Diluted Eps TTM -0.13 USD
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics TLSA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History TLSA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 2499:1000
Payout Ratio
Last Split Date 31.07.2020
Dividend Date

Stock Valuation TLSA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -5.9804
Price Book MRQ 52.0513

Financials TLSA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TLSA

For 52 weeks

0.41 USD 1.74 USD
50 Day MA 0.95 USD
Shares Short Prior Month 60 592
200 Day MA 0.8 USD
Short Ratio 0.3
Shares Short 53 735
Short Percent 0.09 %